Three doses of an inactivation-based COVID-19 vaccine induces cross-neutralizing immunity against the SARS CoV-2 Omicron variant

The immunity potency upon natural infection or vaccination is the main concern for the vaccine strategy of severe acute respiratory syndrome coronavirus 2 (SARS COV-2 variant), especially the recently reported Omicron variant (B.1.1.529). In this study, 200 recipients immunized with three doses of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Xiaoling, Qi, Xiangrong, Cao, Yu, Li, Peiyao, Lu, Li, Wang, Pingping, Feng, Yuchen, Yang, Jie, Wei, Huihui, Guo, Lixian, Sun, Mingyue, Liu, Qiang, Lv, Jing, Feng, Yingmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronaviruses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903785/
https://www.ncbi.nlm.nih.gov/pubmed/35176972
http://dx.doi.org/10.1080/22221751.2022.2044271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903785/
https://www.ncbi.nlm.nih.gov/pubmed/35176972
http://dx.doi.org/10.1080/22221751.2022.2044271

Ejemplares similares